RxDoctor Payments DataLook up a doctor →

Lakan Karlo Magat, MD

Family Medicine · Wilmington, DENPI 1033151642

Payments from drug & device makers

$15,566in general payments, 2019–2025

Across 695 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • GSK$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$2K
  • AbbVie$1K
  • Boehringer Ingelheim$892
  • plus $5K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca102$2,505
GSK81$2,023
Novo Nordisk114$1,984
Lilly USA, LLC66$1,653
AbbVie(2 entities)51$1,125
Boehringer Ingelheim33$892
Pfizer64$860
Sanofi-aventis U.S. LLC20$666
Astellas Pharma US Inc29$535
Amgen14$456
Merck13$285
Shield Therapeutics Inc9$244
Amarin Pharma, Inc.10$231
Exact Sciences11$230
Johnson & Johnson7$211
Abbott5$208
Avanir Pharmaceuticals, Inc.3$143
E.r. Squibb & Sons, L.L.C.7$141
Esperion Therapeutics, Inc.2$131
Eisai Inc.7$127
Kowa Pharmaceuticals America, Inc.9$124
Novartis3$121
Kvk-tech, Inc.1$86
Takeda Pharmaceuticals U.S.A., Inc.7$84
Bayer3$64
Xeris Pharmaceuticals, Inc.3$56
Endo Pharmaceuticals Inc.3$43
Biohaven Pharmaceutical Holding Company Ltd.2$42
Genentech USA, Inc.2$39
Biohaven Pharmaceuticals, Inc.2$36
Insulet Corporation1$34
Hikma Pharmaceuticals USA2$33
Phathom Pharmaceuticals, Inc.2$30
Tactile Systems Technology Inc1$26
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$23
Gilead1$20
Arbor Pharmaceuticals, Inc.1$16
Currax Pharmaceuticals LLC1$14
Circassia Inc.1$13
Mission Pharmacal Company1$13

How this compares

$15,566 in reported general payments places this provider in the 95th percentile of 352 family medicine providers in Delaware.

See all family medicine providers in Delaware →

Medicare billing

Part B allowed, 2024
$103,653
Medicare patients
265
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Wilmington

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →